Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in PRME — Prime Medicine, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,422,615
+$230,718 QoQ
Shares Held
927,538
+1.1% QoQ
Ownership
0.511%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 186 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. PRME ranks #164 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,422,615 927,538
2026-03-31 $3,191,897 917,212
2025-12-31 $3,250,748 936,815
2025-09-30 $3,175,295 573,158
2025-06-30 $1,281,011 518,628
2025-03-31 $1,002,357 503,697
2024-12-31 $1,415,005 484,591
2024-09-30 $1,795,590 463,977
2024-06-30 $2,530,221 492,261
2024-03-31 $2,084,761 297,823
2023-12-31 $2,624,225 296,188
2023-09-30 $2,791,117 292,570
2023-06-30 $2,067,759 141,144
2023-03-31 $903,152 73,427
2022-12-31 $1,322,598 71,184